Institut d'Investigacions Biomèdiques August Pi i Sunyer-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2024

  1. Profile of Patients With Moderate-to-Severe Atopic Dermatitis and Chronic Urticaria Undergoing Biological Treatment in Hospital Allergy Units in Spain: First Report of the Alergodata Registry

    Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 2, pp. 131-133

2023

  1. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

2019

  1. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)

    Health and Quality of Life Outcomes, Vol. 17, Núm. 1

  2. Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria giménez

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 338-348

2018

  1. Eosinophilic esophagitis: Review and update

    Frontiers in Medicine, Vol. 5, Núm. OCT

2017

  1. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe

    Rhinology, Vol. 55, Núm. 1, pp. 34-38

  2. Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells

    Scientific Reports, Vol. 7, Núm. 1

2015

  1. Management of urticaria: Not too complicated, not too simple

    Clinical and Experimental Allergy, Vol. 45, Núm. 4, pp. 731-743

2013

  1. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain

    Pediatric Allergy and Immunology, Vol. 24, Núm. 7, pp. 678-684

  2. ESPRINT-15 questionnaire (Spanish version): Reference values according to disease severity using both the original and the modified ARIA classifications

    Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 1, pp. 14-19

2012

  1. The impact of allergic rhinitis on symptoms, and quality of life using the new criterion of ARIA severity classification

    Rhinology, Vol. 50, Núm. 1, pp. 33-36

  2. Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: The PEDRIAL study

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 67, Núm. 11, pp. 1437-1442

2011

  1. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: The PEDRIAL study

    Pediatric Allergy and Immunology, Vol. 22, Núm. 4, pp. 388-392

2010

  1. Discrimination between moderate and severe disease may be used in patients with either treated or untreated allergic rhinitis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 65, Núm. 12, pp. 1609-1613

2009

  1. Allergic conjunctivitis and H1 antihistamines

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. SUPPL. 1, pp. 11-18

  2. Allergic rhinitis and school performance

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. SUPPL. 1, pp. 32-39

  3. From pollinosis to digestive allergy

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. SUPPL. 1, pp. 3-10

  4. Genetic aspects of allergic rhinitis

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. SUPPL. 1, pp. 25-31

  5. Molecular diagnosis in allergology: Application of the microarray tecnique

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. SUPPL. 1, pp. 19-24

  6. Stress and allergy

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. SUPPL. 1, pp. 40-47